Pulse Biosciences expands ATM to allow insider purchases; major holder and CEO indicate likely buying

PULSE BIOSCIENCES, INC.

Board authorized TD Cowen to sell shares to affiliates under existing ATM with up to $60M aggregate offering.
Robert Duggan (72% owner) and CEO Paul LaViolette indicate they are likely to purchase shares in near term.
No binding commitments or share counts; purchases would be at prevailing market bid or better.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.